DK4069278T3 - Fremgangsmåder og sammensætninger til forebyggelse af type 1-diabetes - Google Patents
Fremgangsmåder og sammensætninger til forebyggelse af type 1-diabetesInfo
- Publication number
- DK4069278T3 DK4069278T3 DK20896240.7T DK20896240T DK4069278T3 DK 4069278 T3 DK4069278 T3 DK 4069278T3 DK 20896240 T DK20896240 T DK 20896240T DK 4069278 T3 DK4069278 T3 DK 4069278T3
- Authority
- DK
- Denmark
- Prior art keywords
- diabetes
- compositions
- methods
- preventing type
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944503P | 2019-12-06 | 2019-12-06 | |
| PCT/US2020/062159 WO2021113136A1 (en) | 2019-12-06 | 2020-11-25 | Methods and compositions for the treatment and prevention of type 1 diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4069278T3 true DK4069278T3 (da) | 2025-06-30 |
Family
ID=76222225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20896240.7T DK4069278T3 (da) | 2019-12-06 | 2020-11-25 | Fremgangsmåder og sammensætninger til forebyggelse af type 1-diabetes |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230018324A1 (da) |
| EP (2) | EP4069278B1 (da) |
| JP (1) | JP2023505190A (da) |
| CN (1) | CN115151273A (da) |
| AR (1) | AR122339A1 (da) |
| AU (1) | AU2020398147A1 (da) |
| CA (1) | CA3159054A1 (da) |
| DK (1) | DK4069278T3 (da) |
| FI (1) | FI4069278T3 (da) |
| PL (1) | PL4069278T3 (da) |
| TW (1) | TW202133876A (da) |
| WO (1) | WO2021113136A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230018324A1 (en) * | 2019-12-06 | 2023-01-19 | Dr. Mary Morris & Associates, Llc | Methods and compositions for the treatment and prevention of type 1 diabetes |
| CN116847869A (zh) * | 2020-10-08 | 2023-10-03 | 美商玛丽莫里斯博士联合有限责任公司 | 用于治疗和预防1型糖尿病的方法和组合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1242121E (pt) * | 1999-12-16 | 2005-05-31 | Lilly Co Eli | Composicoes polipeptidicas com estabilidade melhorada |
| EP1578432A4 (en) * | 2002-10-03 | 2008-07-30 | Epimmune Inc | HLA BINDING PEPTIDES AND USES THEREOF |
| DE602004015980D1 (de) * | 2003-06-17 | 2008-10-02 | Sembiosys Genetics Inc | Verfahren zur insulinproduktion in pflanzen |
| US20070027063A1 (en) * | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
| PL1740154T3 (pl) * | 2004-03-12 | 2009-11-30 | Biodel Inc | Kompozycje insuliny o ulepszonym wchłanianiu |
| EP1846438A2 (en) * | 2005-01-31 | 2007-10-24 | Leiden University Medical Center | Methods and means for use in diagnostics and treatment of diabetes |
| AU2011202239C1 (en) * | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
| EP2670368A4 (en) * | 2011-02-03 | 2015-04-15 | Pharmedica Ltd | NEW ORAL DISSOLUTION FILMS FOR INSULIN DELIVERY FOR THE TREATMENT OF DIABETES |
| CA2870399A1 (en) * | 2012-04-16 | 2013-10-24 | Alk-Abello A/S | Plant profilin polypeptides for use in non-specific allergy immunotherapy |
| US20190388513A1 (en) * | 2017-02-28 | 2019-12-26 | Biolingus Ip Llc | Oil based formulations for sublingual and buccal delivery |
| EP3418738A1 (en) * | 2017-06-23 | 2018-12-26 | Klinikum rechts der Isar der Technischen Universität München | A ratio of immune cells as prognostic indicator of therapeutic success in allergen-specific immunotherapy |
| HUE057216T2 (hu) * | 2017-09-08 | 2022-04-28 | Diamyd Medical Ab | Genotípus-rétegzés cukorbetegség kezelésében és megelõzésében |
| US20230018324A1 (en) * | 2019-12-06 | 2023-01-19 | Dr. Mary Morris & Associates, Llc | Methods and compositions for the treatment and prevention of type 1 diabetes |
| CN116847869A (zh) * | 2020-10-08 | 2023-10-03 | 美商玛丽莫里斯博士联合有限责任公司 | 用于治疗和预防1型糖尿病的方法和组合物 |
-
2020
- 2020-11-25 US US17/778,624 patent/US20230018324A1/en active Pending
- 2020-11-25 WO PCT/US2020/062159 patent/WO2021113136A1/en not_active Ceased
- 2020-11-25 AU AU2020398147A patent/AU2020398147A1/en active Pending
- 2020-11-25 FI FIEP20896240.7T patent/FI4069278T3/fi active
- 2020-11-25 PL PL20896240.7T patent/PL4069278T3/pl unknown
- 2020-11-25 JP JP2022533345A patent/JP2023505190A/ja active Pending
- 2020-11-25 EP EP20896240.7A patent/EP4069278B1/en active Active
- 2020-11-25 DK DK20896240.7T patent/DK4069278T3/da active
- 2020-11-25 CA CA3159054A patent/CA3159054A1/en active Pending
- 2020-11-25 CN CN202080084253.5A patent/CN115151273A/zh active Pending
- 2020-11-25 EP EP25181562.7A patent/EP4623900A3/en active Pending
- 2020-11-27 TW TW109141906A patent/TW202133876A/zh unknown
- 2020-11-30 AR ARP200103323A patent/AR122339A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230018324A1 (en) | 2023-01-19 |
| TW202133876A (zh) | 2021-09-16 |
| AR122339A1 (es) | 2022-09-07 |
| EP4069278A4 (en) | 2024-01-10 |
| EP4069278A1 (en) | 2022-10-12 |
| WO2021113136A1 (en) | 2021-06-10 |
| JP2023505190A (ja) | 2023-02-08 |
| PL4069278T3 (pl) | 2025-10-06 |
| EP4623900A2 (en) | 2025-10-01 |
| CA3159054A1 (en) | 2021-06-10 |
| FI4069278T3 (fi) | 2025-07-16 |
| EP4623900A3 (en) | 2025-12-10 |
| CN115151273A (zh) | 2022-10-04 |
| AU2020398147A1 (en) | 2022-06-02 |
| EP4069278B1 (en) | 2025-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3880660T3 (da) | Forbindelser og sammensætninger til behandling af tilstande forbundet med nlrp-aktivitet | |
| DK3978580T3 (da) | Stabiliserede fluorolefinsammensætninger og fremgangsmåde til fremstilling, oplagring og anvendelse deraf | |
| DK3864152T5 (da) | Fremgangsmåder og sammensætninger til editering af rna'er | |
| DK4095193T3 (da) | Dyppestøbesammensætning, fremgangsmåde til fremstilling af handske og handske | |
| DK3568494T3 (da) | Fremgangsmåder og sammensætninger til markering af celler | |
| DK3402499T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes | |
| DK4034104T3 (da) | Metoder og forbindelser til genoprettelse af mutant p53-funktion | |
| DK3676297T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
| DK3833682T3 (da) | Selvmordsmolekyle sammensætninger og fremgangsmåder | |
| EP3871694A4 (en) | COMPOSITION | |
| DK3727651T3 (da) | Synergiserede acetal-sammensætninger og fremgangsmåde til opfangning af sulfider og mercaptaner | |
| EP4079787A4 (en) | CURABLE COMPOSITION | |
| DK3947684T3 (da) | Forbindelser og fremgangsmåder til at modulere ube3a-ats | |
| EP3981256A4 (en) | COMPOSITION | |
| DK3892621T3 (da) | Haloallylaminforbindelser og anvendelse deraf | |
| DK4100482T3 (da) | Sammensætninger, der omfatter 2,3,3,3-tetrafluorpropen, og fremgangsmåder til fremstilling og anvendelse af sammensætningerne | |
| EP3757149A4 (en) | CURING COMPOSITION | |
| EP3941942A4 (en) | Composition | |
| DK4069278T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse af type 1-diabetes | |
| DK4223886T3 (da) | Sammensætninger og fremgangsmåder til stabilisering af mikro-rna | |
| DK3953348T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
| DK4062078T3 (da) | Lejearrangement og fremgangsmåde til montering af et sådant | |
| DK4025775T3 (en) | Fremgangsmåde til test af et ventillegeme i en indsprøjtningsventil og fremgangsmåde til test af en indsprøjtningsventil | |
| DK4361228T3 (da) | Formuleringer og fremgangsmåde til generering af afvisende overflader | |
| DK3891260T3 (da) | Sammensætninger til udskylning af hydrogensulfid og methanthioler |